Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo

Figure 2

SW 1353 chondrosarcoma at day 28 after tumor implantation, hematoxylin-eosin stained cross section from representative tissue samples of the cranial window preparation. A, D: 4-fold magnification, scale bar 500 μm. B, C, E, F: 20-fold magnification, scale bar 100 μm. In Controls, the overview magnification shows a large tumor formation with high cellular density (A). Enlarged cutaway views (B, C) from the framed regions show high cellular density and destructive tumor growth with resorption of the surrounding bone (arrows, tips pointing to resorption lacunae). In SU6668, tumor size was markedly reduced (D). Enlarged cutaway views (E, F) from the framed regions show fibrous "scar" tissue with residual tumor cells and low cellular density and regenerative bone formation at sites of previous bone resorption (double arrows, distal tip pointing to former resorption front, proximal tip pointing to new mineralization front).

Back to article page